- Home
- VRPX
as 11-15-2024 4:00pm EST
Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.
| Founded: | 2016 | Country: | United States |
| Employees: | N/A | City: | BERWYN |
| Market Cap: | 3.7M | IPO Year: | 2021 |
| Target Price: | N/A | AVG Volume (30 days): | 108.5K |
| Analyst Decision: | Hold | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -5.91 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.36 - $7.60 | Next Earning Date: | 11-26-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Virpax Pharmaceuticals Inc. News
VRPX Breaking Stock News: Dive into VRPX Ticker-Specific Updates for Smart Investing
Business Wire
2 days ago
Virpax Pharmaceuticals, Inc. Announces Closing of $5.0 Million Public Offering of Common Stock and Pre-Funded Warrants
Business Wire
5 days ago
Virpax Pharmaceuticals, Inc. Announces Pricing of $5.0 Million Public Offering of Common Stock and Pre-Funded Warrants
GlobeNewswire
13 days ago
Adial Pharmaceuticals Appoints Vinay Shah as Chief Financial Officer
Business Wire
3 months ago
Virpax Pharmaceuticals Reports 2024 Second Quarter Results and Recent Developments
Business Wire
3 months ago
Virpax Pharmaceuticals to Present at Sidoti Virtual Investor Conference August 14-15
Business Wire
4 months ago
Virpax Regains Compliance with Nasdaq Minimum Bid Price
Benzinga
4 months ago
Pain Management-Focused Penny Stock Virpax Pharmaceuticals Surges Over 100% On Wednesday-Here's Why?
MT Newswires
4 months ago
Virpax Says Non-Narcotic Pain Medication Shows Positive Results in Swine Model Study; Shares Rise
Compare VRPX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "VRPX Virpax Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.